Loading
A newer potassium binder (Lokelma) that removes potassium through the gut in chronic hyperkalemia.
SZC binds potassium in the gastrointestinal tract, enabling patients with hyperkalemia to continue kidney-protective RAAS inhibitors. It lowers potassium within hours and maintains control daily. It can cause edema (sodium content) and hypokalemia if overused. Patiromer is a similar gut potassium binder with different dosing.
High potassium in the blood — a common and potentially dangerous complication of CKD, especially with ACEi/ARB therapy — causing heart rhythm disturbances at severe levels.
A medication that binds potassium in the gut to lower blood potassium — allowing patients with CKD to stay on protective ACEi/ARB therapy.
A blood-pressure drug (e.g., ramipril, lisinopril, enalapril) that also protects the kidneys by reducing protein leakage.
Potassium obtained from food and drink — the main modifiable driver of blood potassium levels in kidney disease.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.